Your browser doesn't support javascript.
loading
A CD123-specific chimeric antigen receptor augments anti-acute myeloid leukemia activity of Vγ9Vδ2 T cells.
Zhang, Xi; Ang, Wei Xia; Du, Zhicheng; Ng, Yu Yang; Zha, Shijun; Chen, Can; Xiao, Lin; Ng, Jia Yi; Chng, Wee Joo; Wang, Shu.
Afiliación
  • Zhang X; Department of Biological Sciences, National University of Singapore, 117543, Singapore.
  • Ang WX; Department of Biological Sciences, National University of Singapore, 117543, Singapore.
  • Du Z; Department of Biological Sciences, National University of Singapore, 117543, Singapore.
  • Ng YY; Department of Biological Sciences, National University of Singapore, 117543, Singapore.
  • Zha S; Department of Biological Sciences, National University of Singapore, 117543, Singapore.
  • Chen C; Department of Biological Sciences, National University of Singapore, 117543, Singapore.
  • Xiao L; Department of Biological Sciences, National University of Singapore, 117543, Singapore.
  • Ng JY; Department of Haematology-Oncology, National University Cancer Institute Singapore, National University Health System, 119074, Singapore.
  • Chng WJ; Department of Haematology-Oncology, National University Cancer Institute Singapore, National University Health System, 119074, Singapore.
  • Wang S; Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore.
Immunotherapy ; 14(5): 321-336, 2022 04.
Article en En | MEDLINE | ID: mdl-35152722

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Receptores Quiméricos de Antígenos Límite: Animals / Humans Idioma: En Revista: Immunotherapy Asunto de la revista: ALERGIA E IMUNOLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Singapur Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Receptores Quiméricos de Antígenos Límite: Animals / Humans Idioma: En Revista: Immunotherapy Asunto de la revista: ALERGIA E IMUNOLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Singapur Pais de publicación: Reino Unido